Innovating Works

PROBELTE PHARMA

Activa
Impentri: First effective pharmacotherapy for ARDS to lower mortality and improve quality of life of patients. EXVASTAT LTD tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Acute Respiratory Distress syndrome (ARDS) is a life threatening condition that affects 3 million people world-wide. With regards to the cur...
2021-02-18 - 2022-09-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.